13th Annual Liver Transplantation Symposium

Saturday, Dec. 2, 2017

The Hotel Hershey
100 Hotel Road
Hershey, PA 17033

This conference is designed to provide updated information about liver transplantation, including pre- and post-transplant considerations.


Select this button to navigate the sections of this page

Audience

Gastroenterologists, hepatologists, physicians in the primary care setting with patients who have liver failure or are transplant recipients, nurses, nurse practitioners, and physician assistants may all benefit from attendance.

Fee

$65 per person, includes instruction, all listed meals, and online handout materials.

Registrations received after Dec. 1 will incur a $25 late fee.

Credit

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Using AMA Credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in 4.5 hours of approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the Pennsylvania State Board of Nursing.

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

Agenda

  • 8:30 a.m. | Check-in / Continental Breakfast / Visit Exhibitors
  • 9 a.m. | Welcome and Introductions
    Kofi Clarke, MD
  • 9:15 a.m. | Surgical Aspects of Obesity and Transplantation
    Zakiyah Kadry, MD, FACS
    – Identify the transplant surgical risks associated with obesity
    – Describe the effects of obesity in deceased and live liver transplantation
    – Discuss the surgical methods and approaches to obesity in the pre- and peri-transplant phases
  • 9:45 a.m. | What’s the Skinny on Nonalcoholic Fatty Liver Disease (NAFLD)?
    Thomas R. Riley III, MD
    – Review the diagnosis of NAFLD
    – Discuss the pathophysiology of NAFLD
    – Describe the treatment for NAFLD
  • 10:45 a.m. | Get Ready for the Nonalcoholic Steatohepatitis (NASH) Explosion!
    Karen Krok, MD
    – Identify the barriers to screening for hepatocellular carcinoma (HCC) in patients with NASH cirrhosis
    – Recognize the increased incidence of NASH as an indication for liver transplant
  • 11:15 a.m. | Out of the Frying Pan and in to the Fire? NAFLD in the Liver Transplant Recipient
    Ian R. Schreibman, MD, FACG, FAGA
    – Identify the incidence of NAFLD in the post-transplant population
    – Review the mechanisms which lead to NAFLD in the post-transplant population
    – Describe the clinical outcomes of patients with NAFLD who undergo liver transplant
  • 11:45 a.m. | Lunch / Visit Exhibitors
  • 1 p.m. | Keynote Speaker / Should Candidates with High-Risk NASH Undergo Liver Transplantation?
    Jonathan G. Stine, MD, MSc, FACP
    – Review the coagulation derangement in patients with NASH cirrhosis
    – Define the high-risk NASH phenotype
    – Debate whether or not liver transplant candidates with high-risk NASH should be approved for listing and receive an organ offer from a deceased donor
  • 1:30 p.m. | Patient Panel Discussion
    Facilitated by Zakiyah Kadry, MD, FACS and Thomas R. Riley III, MD
  • 2 p.m. | Dashing Through the Snow and a Mediterranean Mindset: Nutrition in NAFLD
    Courtney Hager, RDN
    Identify the impact that poor diet has on the liver
    List two diet strategies used to treat NAFLD
  • 2:30 p.m. | Fatty Liver – Fatty Heart
    Dmitri Bezinover, MD, PhD
    – Review of hemodynamic problems associated with end-stage liver disease (ESLD)
    – Recognition of NASH effects on cardiac function
    – Summarize the management of patients with ESLD related to NASH undergoing liver transplantation
  • 3 p.m. | Closing Remarks / Program Adjournment

Planning Committee

  • Dmitri S. Bezinover, MD, PHD
  • Zakiyah Kadry, MD, FACS (Co-course Director)
  • Karen Krok, MD
  • Thomas R. Riley III, MD (Co-course Director)
  • Ian R. Schreibman, MD, FACG, FAGA

Faculty

Penn State Health Milton S. Hershey Medical Center

Courtney Hager, RDN
Clinical Dietician, Transplant
Clinical Nutrition Services

Dmitri S. Bezinover, MD, PHD
Associate Professor
Director, Transplant Anesthesia
Anesthesiology and Perioperative Medicine
Penn State College of Medicine

Kofi Clarke, MD
Professor of Medicine
Chief, Division of Gastroenterology and Hepatology
Penn State College of Medicine

Zakiyah Kadry, MD, FACS
Professor of Surgery
Department of Surgery
Chief, Division of Transplantation
Surgical Director, Liver Transplantation
Penn State College of Medicine

Karen Krok, MD
Associate Professor of Medicine
Director, Live Donor Liver Transplantation
Division of Gastroenterology and Hepatology
Penn State College of Medicine

Thomas R. Riley III, MD
Professor of Medicine
Medical Director
Liver Transplantation
Division of Gastroenterology and Hepatology
Penn State College of Medicine

Ian R. Schreibman, MD, FACG, FAGA
Associate Professor
Division of Gastroenterology and Hepatology
Penn State College of Medicine

Jonathan G. Stine, MD, MSC, FACP
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Penn State College of Medicine

Accommodations

Accommodations are the responsibility of the participant. A list of lodging in the Hershey area is available at the Penn State Health Milton S. Hershey Medical Center website.

Cancellations

Cancellations received after Nov. 24 will incur a $25 processing fee.

No refunds will be available after Nov. 28.

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund registration fees but cannot be held responsible for any related costs, charges, or expenses, including cancellation/ change charges assessed by airlines or travel agencies. Preregistered participants will be notified if a program is filled or canceled.

Access (ADA)

Penn State encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of special accommodation or have questions about the physical access provided, please contact Continuing Education at least one week in advance of your participation or visit.

Disclosure/ Conflict of Interest (COI/ educational balance)

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission, and employment without regard to personal characteristics not related to ability, performance, or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity, or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment, or retaliation against faculty, staff, or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; tel 814-863-0471/TTY.

Jump to ...